Acetyl-d-carnitine

Acetyl-d-carnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2875 references associated with Acetyl-d-carnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Acetyl-d-carnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Acetyl-d-carnitine

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Cleft Lip D002971 8 associated lipids
Proteostasis Deficiencies D057165 5 associated lipids
Total 7

All references with Acetyl-d-carnitine

Download all related citations
Per page 10 20 50 100 | Total 877
Authors Title Published Journal PubMed Link
Laird MD et al. Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels. 2013 Transl Stroke Res pmid:24323418
Brennan BP et al. A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression. 2013 J Clin Psychopharmacol pmid:23948785
Kathirvel E et al. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. 2013 Nutr Res pmid:24176233
Wu SN et al. [Analysis of propionylcarnitine in blood and methylmalonic acid in urine of 162 patients with methylmalonic acidemia]. 2013 Zhonghua Yi Xue Za Zhi pmid:23663331
Morand R et al. Quantification of plasma carnitine and acylcarnitines by high-performance liquid chromatography-tandem mass spectrometry using online solid-phase extraction. 2013 Anal Bioanal Chem pmid:23995505
Burotto M and Fojo AT Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work? 2013 Oncologist pmid:24217999
Campone M et al. A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy. 2013 Oncologist pmid:24105751
Wang CH et al. Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats. 2013 PLoS ONE pmid:23922880
Babicová A et al. In vivo study of radioprotective effect of NO-synthase inhibitors and acetyl-L-carnitine. 2013 Physiol Res pmid:23869893
Hershman DL et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. 2013 J. Clin. Oncol. pmid:23733756
Cuccurazzu B et al. Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine. 2013 Neuropsychopharmacology pmid:23670591
Ryckman KK et al. The influence of maternal disease on metabolites measured as part of newborn screening. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23550828
Hanada H et al. Acetyl-L-carnitine suppresses thyroid hormone-induced and spontaneous anuran tadpole tail shortening. 2013 Hereditas pmid:23489246
Ren J et al. Dynamic monitoring of carnitine and acetylcarnitine in the trimethylamine signal after exercise in human skeletal muscle by 7T 1H-MRS. 2013 Magn Reson Med pmid:22473634
Pekkinen J et al. Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach. 2013 Mol Nutr Food Res pmid:23868375
Schloss JM et al. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review. 2013 Clin Nutr pmid:23647723
Gómez LA et al. Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the L-carnitine content in the rat heart. 2012 Feb-Mar Mech. Ageing Dev. pmid:22322067
Hu S et al. Use of hyperpolarized [1-13C]pyruvate and [2-13C]pyruvate to probe the effects of the anticancer agent dichloroacetate on mitochondrial metabolism in vivo in the normal rat. 2012 Magn Reson Imaging pmid:22819176
Zaitone SA et al. Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy. 2012 Pharmacol. Biochem. Behav. pmid:21958946
Mallinson JE et al. Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. 2012 J. Physiol. (Lond.) pmid:23045346
Wadman RI et al. Drug treatment for spinal muscular atrophy types II and III. 2012 Cochrane Database Syst Rev pmid:22513940
Muoio DM et al. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. 2012 Cell Metab. pmid:22560225
Balschi JA In vivo clinical measures of intermediary metabolism are inadequate: can a new magnetic resonance spectroscopy technology do better? 2012 Circ Cardiovasc Imaging pmid:22438422
Schroeder MA et al. The cycling of acetyl-coenzyme A through acetylcarnitine buffers cardiac substrate supply: a hyperpolarized 13C magnetic resonance study. 2012 Circ Cardiovasc Imaging pmid:22238215
Kanazirska MV et al. Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells. 2012 Curr Pharm Biotechnol pmid:23072393
Malaguarnera M Carnitine derivatives: clinical usefulness. 2012 Curr. Opin. Gastroenterol. pmid:22333562
Schaevitz LR et al. Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome. 2012 PLoS ONE pmid:23227269
Morand R et al. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans. 2012 Ther Drug Monit pmid:22743351
Muralidharan AR et al. Deciphering the potential efficacy of acetyl-L-carnitine (ALCAR) in maintaining connexin-mediated lenticular homeostasis. 2012 Mol. Vis. pmid:22876134
Karalija A et al. Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats. 2012 PLoS ONE pmid:22815926
Sharma S et al. Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I. 2012 Free Radic. Biol. Med. pmid:22583703
Patel SP et al. Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery. 2012 Neuroscience pmid:22445934
Zhang R et al. Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro. 2012 Int J Mol Sci pmid:22408439
Hu C et al. Inhibition of OCTN2-mediated transport of carnitine by etoposide. 2012 Mol. Cancer Ther. pmid:22389472
Wu R et al. Metabolomic analysis reveals that carnitines are key regulatory metabolites in phase transition of the locusts. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22328148
Boss A et al. Skeletal muscle ¹H MRSI before and after prolonged exercise. II. visibility of free carnitine. 2012 Magn Reson Med pmid:22287218
Pochini L et al. The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease. 2012 Biochim. Biophys. Acta pmid:22206629
Behrend AM et al. Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation. 2012 Mol. Genet. Metab. pmid:22030098
Ang JE et al. Identification of human plasma metabolites exhibiting time-of-day variation using an untargeted liquid chromatography-mass spectrometry metabolomic approach. 2012 Chronobiol. Int. pmid:22823870
Smeland OB et al. Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice. 2012 Neurochem. Int. pmid:22709675
El-Awady el-SE et al. Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies. 2011 Eur. J. Pharmacol. pmid:21034734
Nagesh Babu G et al. Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function. 2011 Neurotox Res pmid:20217290
Mingorance C et al. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. 2011 Vasc Health Risk Manag pmid:21490942
Wadman RI et al. Drug treatment for spinal muscular atrophy types II and III. 2011 Cochrane Database Syst Rev pmid:22161400
Haorah J et al. Stabilization of superoxide dismutase by acetyl-l-carnitine in human brain endothelium during alcohol exposure: novel protective approach. 2011 Free Radic. Biol. Med. pmid:21782933
Jiang X et al. Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C. 2011 J. Neurochem. pmid:21689104
Abdul Muneer PM et al. Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine. 2011 PLoS ONE pmid:21556365
Abdul Muneer PM et al. Inhibitory effects of alcohol on glucose transport across the blood-brain barrier leads to neurodegeneration: preventive role of acetyl-L: -carnitine. 2011 Psychopharmacology (Berl.) pmid:21079922
Boss A et al. Noninvasive assessment of exercise-related intramyocellular acetylcarnitine in euglycemia and hyperglycemia in patients with type 1 diabetes using ¹H magnetic resonance spectroscopy: a randomized single-blind crossover study. 2011 Diabetes Care pmid:20978101
Ponte F et al. Protective effect of acetyl-l-carnitine and α-lipoic acid against the acute toxicity of diepoxybutane to human lymphocytes. 2011 Toxicology pmid:21807063

Table of Content